PRI-MED MIDWEST

Transcription

PRI-MED MIDWEST

PRI-MED MIDWEST
October 15, 2014: Primary Care Updates
October 16–18, 2014: Annual Conference
Rosemont, IL
Donald E. Stephens Convention Center
Please Join Us for a Product Theater Lunch Presentation at
Pri-Med Midwest 2014
HEPATIC ENCEPHALOPATHY:
A Clinical Dialogue on a Chronic
Complication of Cirrhosis
Friday, October 17, 2014
11:50 am – 12:35 pm
Presentation Theater #3 – Room 1, Level 1
Rosemont, Illinois
Ilan S. Weisberg, MD, MSc
Director of Hepatology, Lenox Hill Hospital
Instructor in Medicine, NYU Medical Center
New York, New York
This is a promotional event. CE/CME credit will not be available for this session.
In compliance with PhRMA guidelines, spouses or other guests are not permitted to attend companysponsored programs. This promotional educational activity is brought to you by Salix Pharmaceuticals
and is not certified for continuing medical education. The speakers are presenting on behalf of
Salix Pharmaceuticals and must present information in compliance with FDA requirements applicable
to Salix Pharmaceuticals.
If you are licensed in any state or other jurisdiction (eg, VT, Wash. DC, ME, MN) or are an employee or
contractor of any organization or governmental entity that limits or prohibits meals from pharmaceutical
companies, please identify yourself so that you (and we) are able to comply with such requirements.
Your name, the value, and the purpose of any educational item, meal, or other items of value you receive
may be reported as required by state or federal law. Once reported, this information may be publicly
accessible.
Thank you for your cooperation.
Indication
XIFAXAN® (rifaximin) 550 mg tablets are indicated for reduction in risk of overt hepatic encephalopathy (HE) recurrence in patients ≥ 18 years of age.
Important Safety Information about XIFAXAN 550 mg
XIFAXAN® (rifaximin) 550 mg tablets are contraindicated in patients with a hypersensitivity to rifaximin, any of the rifamycin antimicrobial agents, or any of the components in
XIFAXAN. Hypersensitivity reactions have included exfoliative dermatitis, angioneurotic edema, and anaphylaxis.
Clostridium difficile-associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including XIFAXAN, and may range in severity from mild diarrhea
to fatal colitis. Treatment with antibacterial agents alters the normal flora of the colon which may lead to overgrowth of C. difficile. If CDAD is suspected or confirmed, ongoing
antibiotic use not directed against C. difficile may need to be discontinued.
There is increased systemic exposure in patients with more severe hepatic dysfunction. The clinical trials were limited to patients with MELD scores < 25. Therefore, caution
should be exercised when administering XIFAXAN to patients with severe hepatic impairment (Child-Pugh C).
Concomitant administration of drugs that are P-glycoprotein (P-gp) inhibitors with XIFAXAN can substantially increase the systemic exposure to XIFAXAN. Caution should be
exercised when concomitant use of XIFAXAN and a P-gp inhibitor such as cyclosporine is needed. In patients with hepatic impairment, a potential additive effect of reduced
metabolism and concomitant P-gp inhibitors may further increase the systemic exposure to XIFAXAN.
Based on animal data, XIFAXAN may cause fetal harm. Discontinue in nursing mothers after taking into account the importance of the drug to the mother.
The most common adverse reactions occurring in ≥ 10% of patients and at a higher incidence than placebo in the clinical study were peripheral edema (15%), nausea (14%),
dizziness (13%), fatigue (12%), and ascites (11%).
Presented by
Xifaxan 550 mg is licensed by Alfa Wassermann S.p.A. to Salix Pharmaceuticals, Inc.
Please see complete Prescribing Information at XIFAXAN550.com.
© 2014 Salix Pharmaceuticals, Inc.
08/14
XIFH10-0114
General Conference Information Primary Care Updates Sessions Annual Conference Session Schedule
Featured CME Sessions
Continuing Medical Education Information
Primary Care Updates Session Information
Annual Conference Session Information
Speaking Faculty for Primary Care Updates
and Annual Conference
Financial Disclosures
Exhibitors Maps of the Convention Center 4
6
8-11
12
14-16
18-19
19-22
24-25
26-27
28-31
32-35
General Conference Information
Table of Contents
3
Ticket Booth*: Main Lobby, Level 1
Thursday, October 16
Friday, October 17
Saturday, October 18
6:45am–4:30pm
6:45am–4:30pm
6:45am–12 noon
*Ticket booth will remain open each day until all available tickets have been distributed.
Exhibit Hall: Hall A, Level 1
Friday, October 17
8:30am–2:30pm
8:30am–2:30pm
8:30am–2pm
•
6:45am–3:30pm
6:45am–4:30pm
6:45am–4:30pm
6:45am–12 noon
ROSEMONT
Wednesday, October 15
Friday, October 17
PRI-MED MIDWEST ANNUAL CONFERENCE
Registration: Main Lobby, Level 1
OC TOBER 2014
Hours of Operation
Annual Conference Syllabi
The outlines of the lectures presented in the
Pri-Med Midwest program are available online at
www.pri-med.com/11MDW14A/syllabus for
eight weeks following the conference.
Badge and Attendance Scan Card
4
As a Pri-Med registrant, you will receive a badge that will
have a QR code programmed with just your badge ID. You
need to scan your QR code at the appropriate stations
to obtain CME credit or nursing contact hours. Scanning
your badge at an exhibit booth or non-CME activity
means that you are giving the sponsor the option to use
your contact information for future correspondence.
NEW PROCESS for Evaluation
and Claiming Education Credit
1. Scan your badge. Be sure to scan your badge once each
day near the registration area to activate your identification
for your credit award.
2. Evaluate and Claim Credit. Using any internet-interactive
device go to www.pri-med.com/11MDW14A/eval to
access the evaluation and credit site. You have 7 days to
complete this process - until Oct. 25. A limited number
of computers are available onsite, and Pri-Med staff can
assist you.
A. Enter your badge number and
email address for identification.
ROSEMONT
•
OC TOBER 2014
B. Select the day for the sessions you attended.
The Management Office is located in Room 43 on Level 2. You
are invited to visit us in this office anytime you feel that we can
be of assistance to you.
Parking
Parking is available across the street from the Convention
Center at the Rosemont public parking garage. A sky bridge is
connected to the Convention Center for your convenience.
• Self-parking is $13 for all day.
Questions?
We’re here to help! Please visit the Information Booth located
on Level 1 in the Main Lobby or the Pri-Med Booth #530 or
find any Pri-Med staff member for assistance. Have general
questions, please call 877-477-4633.
Spouse/Children Attendance
Our credit award procedure has changed. Please follow these
instructions for evaluating and claiming continuing education
credit for sessions you attend at this Pri-Med meeting:
C. On the session screen, identify and
evaluate the sessions that you attended.
D. Confirm total credit award for each session and attest
to correct total. Designate the type of credit you seek.
3. Receive Your Credit. View and print your certificate right
from the evaluation web site. Your certificate will also be
posted to your Pri-Med.com account the next day.
Badge Correction/Lost Badges
If you have lost your badge or the badge has been prepared
incorrectly, please go to the Pri-Med Registration Services
Counter located on Level 1 in the Main Lobby, where a new
badge will be prepared.
Lost and Found
Management Office
Any lost and found items can be delivered/picked up at the
Information Booth located on Level 1 in the Main Lobby.
Spouses and/or significant others of registered professional
attendees may enter the Pri-Med Exhibit Hall when
accompanied by a professional attendee. These individuals
should go to the registration area and register for a guest
badge for $35. We regret that because of space limitations
we cannot accommodate guest registrants in the conference
sessions.
So that we can provide all Pri-Med attendees with optimal learning
environments, children under the age of 16 are not permitted in the
Exhibit Hall.
Wi-Fi Access
1. The Donald E. Stephens Convention Center offers wireless
Internet access for $9.95 per day. Here’s how to connect in
three easy steps. Set your wireless network to the Boingo
hotspot.
2. Launch your Web browser.
3. Click on the “Get Online Now” button on the website and
enter payment information.
Notice: Physician Payment Sunshine Act
In compliance with federal regulations, physicians are advised
that their information, including their name and the value and
purpose of any meal, beverage, educational item, or other
items of value they receive from a pharmaceutical, medical
device manufacturer, or group purchasing organization may
be reported by these organizations for public disclosure.
If you have questions or are unsure whether an item you wish
to accept is reportable, please ask a company representative
at the appropriate booth for more information.
For the full Physician Payment Sunshine Act policy, visit
www.CMS.gov under Regulations and Guidance, National
Physician Payment Transparency Program (Open Payments).
SEE YOU NEXT YEAR!
Register for the 2015 Annual Conference (October 14-17, 2015) at the Pri-Med Booth #530
or at the Registration Desk. Registration is available at the lowest cost of $40.
REGISTER
REGISTER FOR NEX T YEAR’S
ANNUAL CONFERENCE FOR JUST $40.
PRI-MED MIDWEST
OC TOBER 14-17, 2015
ROSEMONT, IL
Follow the orange footsteps in the
Exhibit Hall to the Pri-Med Booth #530
or visit Registration in the Main Lobby, Level 1.
Primary Care Updates
Wednesday, October 15, 2014
Primary Care Updates
Track 1 Room 23, Level 2
ROSEMONT
•
OC TOBER 2014
6
Track 2 Room 26, Level 2
7:45–9:15am
Current Approaches to Infectious Diseases in Primary Care
Mark E. Rupp, MD
7:45–9am
Psoriasis: It Runs Deeper Than You Think. Optimizing Patient Communication
Management
April W. Armstrong, MD, MPH
Joel M. Gelfand, MD, MSCE
9:15–9:30am
Networking Break
9–9:15am
Networking Break
9:30–10:45am
Managing Shift Work Disorder in Primary Care: Overcoming Barriers to
Improve Patient Outcomes
Charles A. Czeisler, MD, PhD, FRCP
Karl Doghramji, MD
Paul P. Doghramji, MD, FAAFP
9:15–10:30am
Keeping Adult Patients Healthy: The Role of Adult Immunization
Robert H. Hopkins Jr, MD, FACP, FAAP
M. Susan Burke, MD, FACP
10:45am–Noon
Clinical Significance and Treatment of Hypertriglyceridemia: Overcoming
Challenging Patient Cases
Alan S. Brown, MD, FACC, FNLA
Kevin Maki, PhD, CLS, FNLA
10:30am–Noon
Against All Odds: Improving Insulin Use in T2DM through Individualized
Clinical Decision Making
Frank Lavernia, MD
Richard Pratley, MD
Jeffrey Unger, MD
Noon–12:45pm
Lunch Break
Noon–12:45pm
Lunch Break
12:45–2pm
Improving Outcomes in Type 2 Diabetes: Integrating GLP-1 Receptor Agonists
into Multimodal Treatment Regimens
Vivian A. Fonseca, MD
Lawrence Blonde, MD, FACP, FACE
TBD
12:45–2pm
A Hypoglycemia-Centric Approach to the Management of Type 2 Diabetes
TBD
TBD
2–2:15pm
Networking Break
2–2:15pm
Networking Break
2:15–3:30pm
Clinical Assessment of the Older Patient for Driving Fitness
Linda Hill, MD,MPH
2:15–3:30pm
A Focus on Bipolar Depression: Overcoming Diagnostic Barriers and
Optimizing Long-Term Patient Outcomes
TBD
TBD
Session times are preliminary. Sessions and schedule subject to change. These activities are provided by pmiCME.
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 1: AstraZeneca and Teva CNS.
To date, the following organizations have provided educational grants in support of Primary Care Updates Track 2: Celgene Corporation; Merck & Co., Inc.; Novartis
Pharmaceuticals Corporation; Novo Nordisk Inc.; and Sunovion Pharmaceuticals Inc.
Industry Sponsored CME Sessions
To download Syllabus, please visit: www.pri-med.com/11MDW14A/syllabus
TICKETING
A new ticketing policy is being implemented to give all attendees equal
opportunity to attend the Ticketed Events within the conference, such as
Presentation Theaters and Educational Symposia.
Distribution of all tickets will happen at the Ticket Booth located in the
Main Lobby on Level 1 on a first-come, first-served basis beginning at
6:45 each morning, as follows:
DATE
TICKET DETAILS
TICKET BOOTH HOURS
Ticket pick-up is available for Thursday’s
Ticketed Events only.
Limit 2 tickets per person.
6:45am–4:30pm
Friday, October 17
Ticket pick-up is available for Friday and
Saturday Ticketed Events.
6:45am–4:30pm
Ticket pick-up is available for any remaining
tickets—contigent upon selling out.
6:45am–12 noon
The Ticket Booth is located in the Main Lobby, Level 1 and will be open during the
above hours, or until tickets are no longer available.
Pri-Med Midwest Sessions
Annual Conference curriculum developed in collaboration with the American College of Physicians.
Hands-on workshops on the latest ultrasound technologies developed in collaboration with the
University of South Carolina School of Medicine Ultrasound Institute.
Thursday, October 16, 2014
7:45–8:45am
KEYNOTE: The Power of Lifestyle Changes, Social Networks, & Trust
Dean Ornish, MD
Session Schedules
Hall A, Level 1
8:45–9:45am
NETWORKING BREAK AND ADDITIONAL OPPORTUNITIES
8:55–9:40 am
Rethink HCV
Brought to you by Gilead Sciences, Inc.
The Effect of a Once-Weekly Therapy on A1C and Weight Over 3 Years
Brought to you by AstraZeneca Pharmaceuticals LP
Exhibit Hall, Theater 1
Clinical Pearls in Pulmonary Medicine
Christopher Fanta, MD
Ultrasound for the PCP
Richard Hoppmann, MD, FACP
Hall A, Level 1
Room 23, Level 2
Hypertension Management: A Moving Target
Karol Watson, MD, PhD, FACC
Introduction to Ultrasound and Case Presentations
Richard Hoppmann, MD, FACP; Victor Rao, MBBS, DMRD, RDMS;
Michael Wagner, MD; Keith Barron, MD
9:45–10:45am
10:45–11:45am
Hall A, Level 1
Room 23, Level 2
11:45am–1:45pm
11:50am–12:35pm
Addressing Chronic Weight Management
With Targeted Pharmacotherapy
Brought to you by Eisai, Inc.
Understanding the Data Exocrine Pancreatic Insufficiency
Brought to you by AbbVie
8
Supporting Nurse Practitioners and Physician
Assistants in Diabetes Care: Targeting the
Kidney in Type 2 Diabetes
Brought to you by Janssen Pharmaceuticals, Inc.
ROSEMONT
•
OC TOBER 2014
Room 1, Level 1
Hands-on workshops on the latest ultrasound technologies developed in collaboration with the
University of South Carolina School of Medicine Ultrasound Institute.
Addressing Renal-Mediated Glucose
Homeostasis: Diabetes and the Kidney
Mark Stolar, MD
Supported by an educational grant from AstraZeneca
Hot Off the Press and into Your Practice
2014
Michael Bloch, MD, FACP, FASH
Hall A, Level 1
3–3:45pm
Comprehensive Management of Injury and
Chronic Pain
James Atchison, DO
Hall A, Level 1
Room 23, Level 2
Room 41, Level 2
Hands-on diagnostic workshops developed with
The University of South Carolina School of Medicine
Ultrasound Institute offered at an additional cost.
Ultrasound Workshops will include six rotating
modules on:
1) Neck (thyroid, and ultrasound principles)
2) Basic ECHO
Medical Brain Game 2014: PCP Edition
John Russell, MD; Neil Skolnik, MD
Room 23, Level 2
3) Aorta
4) Inferior Vena Cava
5) Abdomen (gallbladder and liver)
6) Knee (includes guided procedures)
3:45–4pm
NETWORKING BREAK
4–5pm
Lyme Disease Update
John P. Flaherty, MD
Update In Geriatrics 2014
Lee Lindquist, MD, MPH, MBA
Hall A, Level 1
Room 23, Level 2
A Tale of Two Brains
Salvatore Mangione, MD
Top 10 Changes to My Practice 2014
Frank Domino, MD
Hall A, Level 1
Room 23, Level 2
5–6pm
Noon–4pm
9
To date, the following organization has provided an educational grant in support of Pri-Med Midwest:
Annual Conference: AstraZeneca.
Session times are preliminary. Sessions and schedule are subject to change.
Pri-Med Midwest is provided by pmiCME.
ACCME Accreditation Statement: pmiCME is accredited by the Accreditation Council for Continuing Medical
Education to provide continuing medical education for physicians.
AMA PRA Designation Statement: pmiCME designated this live activity for a maximum of 19 AMA PRA Category 1
Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AANP Providership: pmiCME is approved as a provider of nurse practitioner continuing education by the
American Association of Nurse Practitioners. AANP provider number 040308. This program has been approved for
19 contact hours of continuing education (which includes 9.5 hours of pharmacology).
pmiCME certified CME curriculum developed in collaboration with the ACP
Non-CME session supported by industry
pmiCME certified CME session supported by industry
pmiCME certified CME symposium offering additional credit
pmiCME certified CME curriculum developed in collaboration with
UofSC School of Medicine Ultrasound Institute
Session Schedules
Medical Mystery: A Case of Unexplained
Recurrent Abdominal Pain
Brought to you by Shire
OC TOBER 2014
1:45–3pm
Advancing Paradigm Changes in Type 2
Diabetes Management
Currently at capacity—registration was required at an
additional cost.
Distribution of tickets for ticketed
events will happen at the Ticket
Booth, located in the Main Lobby
on Level 1, beginning at 6:45 each
morning, as follows:
Friday, October 17: Ticket pickup is available for Friday ticketed
events. Limit 2 tickets per person.
Saturday, October 18: Ticket
pick-up is available for Saturday
and Sunday ticketed events.
•
Room 29, Level 2
12:55–1:40 pm
Ultrasound Workshops
ROSEMONT
Lunch Symposium: Engaging Your Patient in Obesity Management: Techniques, Tactics,
and Tools for Customized Disease Treatment
Supported by an educational grant from Novo Nordisk, Inc.
Noon–1:30pm
7:45–8:45am
KEYNOTE: Power Foods for the Brain
Neal Barnard, MD
8:45–9:45am
8:55–9:40am
Understanding Patient-Specific Factors in
Stroke Prevention in Atrial Fibrillation (SPAF)
Brought to you by Daiichi Sankyo, Inc.
9:45–10:45am
Session Schedules
10:45–11:45am
10
OC TOBER 2014
•
ROSEMONT
Healthy Lifestyle Options
Frank Domino, MD
Challenges with Patient Communication in a Changing Health Care Environment
Daniel Dunham, MD, MPH
Hall A, Level 1
Room 23, Level 2
Diagnosis and Management of Depression in
Primary Care
Cathy Frank, MD
10:45–11:45am
Medical Literature Updates: Pediatric and Family Medicine Edition
Harvey Katz, MD
Hall A, Level 1
Room 23, Level 2
11:45am–1:45pm
11:50am–12:35pm
Let’s Get to the Heart of the Matter:
Treating your African American HF Patients
Brought to you by Arbor Pharmaceuticals, LLC.
Improving Glycemic Control: A New SGLT2 Inhibitor
for the Treatment of Adults with Type 2 Diabetes
Brought to you by Boehringer Ingelheim Pharmaceuticals Inc.
Noon–1:30pm
Hepatic Encephalopathy:
A Clinical Dialogue on a
Chronic Complication of Cirrhosis
Brought to you by Salix Pharmaceuticals, Ltd.
Room 1, Level 1, Theater 3
Lunch Symposium: RAPID—Rheumatoid Arthritis: A Primary Care Initiative for Improved Diagnosis and Outcomes
Supported by an educational grant from Abbvie and Janssen Biotech
Room 29, Level 2
12:55–1:40pm
Pneumococcal Pneumonia and Invasive Disease
in Adults: Help Protect Patients Aged 50+ in
Your Practice
Brought to you by Pfizer, Inc.
A Paradigm Shift In The Treatment of Thrombosis
1:45–2:45pm
2:45–3:45pm
Understanding Triglycerides
Brought to you by AstraZeneca Pharmaceuticals LP
New Insights into Functional Bowel Disorders
William D. Chey, MD, AGAF, FACG, FACP
Treatment of ADHD in Children and Adolescents
Thomas Cummins, MD
Hall A, Level 1
Room 23, Level 2
Treatment of Primary Headache Syndromes
Gerald Smetana, MD
Carpal Tunnel Syndrome
Greg Dumanian, MD
Hall A, Level 1
Room 23, Level 2
3:45–4pm
4–5pm
Assessment of Chronic Sinusitis
David Conley, MD
Patient-Centered Medical Home Model: A Guide for the PCP
Daniel Evans, MD
Hall A, Level 1
Room 23, Level 2
Heart Failure Update for Primary Care
Allen Anderson, MD
Choosing Wisely: How We Can Improve Value in Health Care
David Baker, MD, MPH
Hall A, Level 1
Room 23, Level 2
5–6pm
Session times are preliminary. Sessions and schedule subject to change. Pri-Med Midwest is provided by pmiCME.
ACCME Accreditation Statement: pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide
continuing medical education for physicians.
AMA PRA Designation Statement: pmiCME designated this live activity for a maximum of 19 AMA PRA Category 1 Credits™. Physicians
should claim only the credit commensurate with the extent of their participation in the activity.
AANP Providership: pmiCME is approved as a provider of nurse practitioner continuing education by the American Association of
Nurse Practitioners. AANP provider number 040308. This program has been approved for 19 contact hours of continuing education
(which includes 9.5 hours of pharmacology).
pmiCME certified CME curriculum developed in collaboration with the ACP
Independently (non pmiCME) certified CME symposium offering additional credit
Saturday, October 18, 2014
KEYNOTE: Laughter Is the Best Medicine
Brad Nieder, MD
7:45–8:45am
Hall A, Level 1
8:55–9:40am
Understanding Dupuytren’s Contracture: Disease Awareness
for the General Practitioner
Brought to you by Auxilium Pharmaceuticals, Inc.
9:45–10:45am
10:45–11:45am
Treatment of the Statin-Intolerant Patient
Matthew Sorrentino, MD, FACC, FASH
Hall A, Level 1
Room 23, Level 2
C Difficile Infection in the Community
Fred Lopez, MD, MACP
Update on Celiac Disease and Other Gluten-Related Disorders
Daniel Leffler, MD, MS
Hall A, Level 1
Room 23, Level 2
11:50am–12:35pm
Glucose Removal: An SGLT2i Treatment Option for Adults with
Type 2 Diabetes
Brought to you by AstraZeneca Diabetes
Treatment of Deep Vein Thrombosis (DVT) and Pulmonary
Embolism (PE) and Reducing the Risk of Recurrent DVT and PE
Following Initial Therapy
Brought to you by Bristol-Myers Squibb & Pfizer Inc.
1:45–2:45pm
2:45–3:45pm
Managing Common Issues in Menopausal Women
Kelly Spratt, DO, FACC, FACP
11:45am–1:45pm
12:55–1:40pm
Evaluating and Determining Patients for Cardiac Radionuclide Imaging
Brought to you by Astellas Pharma
Optimizing Inhaler Technique in Patients With Respiratory Diseases
Brought to you by Teva Pharmaceutical Industries Ltd.
The Latest Information in Therapy for Asthma, COPD, and Exercise-Induced
Bronchospasm
Brought to you by Teva Pharmaceutical Industries Ltd.
Dermatologic Manifestations of Systemic Disease
Julia R. Nunley, MD
For Your Eyes Only—Ophthalmology 2014 Update
Tommy Korn, MD, FACS
Hall A, Level 1
Room 23, Level 2
Organize Your Mind for Lifestyle Medicine
Margaret Moore, MBA
Optimizing the Management of Patients with Chronic Kidney Disease
Jay Wish, MD, FACP
Hall A, Level 1
Room 23, Level 2
Session Schedules
8:45–9:45am
11
CME curriculum developed in collaboration with the ACP
•
AANP Providership: pmiCME is approved as a provider of nurse practitioner continuing education by the American Association of
Nurse Practitioners. AANP provider number 040308. This program has been approved for 19 contact hours of continuing education
ROSEMONT
AMA PRA Designation Statement: pmiCME designated this live activity for a maximum of 19 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ACCME Accreditation Statement: pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide
continuing medical education for physicians.
OC TOBER 2014
Session times are preliminary. Sessions and schedule subject to change. Pri-Med Midwest is provided by pmiCME.
Keynote Addresses
THURSDAY, OCTOBER 16
7:45–8:45am | KEYNOTE ADDRESS
The Power of Lifestyle Changes, Social Networks, & Trust
Dean Ornish, MD
Dean Ornish, MD, is the founder and president of the nonprofit Preventive Medicine Research Institute
and clinical professor of medicine at the University of California, San Francisco. At Pri-Med Midwest,
Dr. Ornish will discuss the power of comprehensive lifestyle changes, reviewing more than 30 years of
research using high-tech, state-of-the-art measures to prove the power of low-tech, low-cost, and often
ancient interventions.
FRIDAY, OCTOBER 17
Power Foods for the Brain
ROSEMONT
•
OC TOBER 2014
12
Neal Barnard, MD
Neal Barnard, MD, is an adjunct associate professor of medicine at the George Washington University
School of Medicine in Washington, D.C., and president of the Physicians Committee for Responsible
Medicine. Dr. Barnard has led numerous research studies investigating the effects of diet on diabetes,
body weight, and chronic pain, including a groundbreaking study of dietary interventions in type
2 diabetes funded by the National Institutes of Health. Dr. Barnard has authored dozens of scientific
publications as well as 15 books. As president of the Physicians Committee, Dr. Barnard leads programs
advocating for preventive medicine, good nutrition, and higher ethical standards in research. He has hosted three PBS
television programs on nutrition and health and is frequently called on by news programs to discuss issues related to
nutrition and research.
SATURDAY, OCTOBER 18
Laughter Is the Best Medicine
Brad Nieder, MD
Brad Nieder, MD, is a funny doctor, keynote speaker, and clean comedian who blends health care humor
with wellness advice and an uplifting message. Audiences love his “Laughter Is the Best Medicine”
program, finding it entertaining and inspiring (and informative too, as Dr. Brad explains–without being
boring–how laughter really is good medicine ... for managing pain, enhancing immune system function,
reducing stress, and more).
KNOWLEDGE ZONE
The Knowledge Zone is the single best source for small group presentations and
opportunities for 1:1 discussions with industry experts. Topics focus on health
and wellness through the eyes of preventive care, diagnosis, treatment decisions,
and patient adherence.
Located in the Exhibit Hall in Booth #611.
DATE
TIME
TITLE
PRESENTED BY
11:55am - 12:10pm
Non-invasive Peripheral Small Nerve
Fiber Testing within the Physician
Impeto Medical
Office
12:35-12:50pm
Problem-Oriented Medical Record
(POMR)
InLight
12:55-1:10pm
Document More with Fewer Clicks
Amazing Charts
9-9:15am
Shave Biopsy - Keep It Simple
Personna Industrial
12:35-12:50pm
(POMR)
InLight
12:55-1:10pm
Amazing Charts
9-9:15am
(POMR)
InLight
9:20-9:35am
Amazing Charts
Primary Care Updates – October 15, 2014
Annual Conference CME Information
Target Audience
This program is intended for clinicians in primary care, family
medicine, pediatrics, and internal medicine.
14
Learning Objectives for Primary Care Updates
Sessions*
• Assess new information on new guidelines, practices,
therapies, and/or tools that you can use to diagnose, treat,
and/or manage health problems you see in your practice.
• Evaluate applicability of the new information to your
own practice and specific opportunities to improve your
patients’ quality of care and health outcomes.
OC TOBER 2014
•
ROSEMONT
AAPA accepts certificates of participation for educational
activities certified for AMA PRA Category 1 credit™ from
organizations accredited by ACCME. Physician assistants
may receive a Certificate of Attendance for a maximum of
6.5 hours of AMA PRA Category 1 credit™ for completing this
program.
Nurse Practitioners:
pmiCME is approved as a provider of nurse practitioner
continuing education by the American Association of
Nurse Practitioners. AANP provider 040308. This program
has been approved for 6.5 contact hours of continuing
education (which includes 3.25 hours of pharmacology).
• Demonstrate your ability to adopt the new information
by interactive participation in case-based learning and
discussing common challenges and ways to overcome
barriers to implementation.
*Individual sessions will post topic-specific learning objectives.
Faculty and Financial Disclosures
See pages 24-27 for a full list of program faculty and financial
disclosure information.
Certificate Instructions – NEW
Please see the information noted to the right under
NEW PROCESS for Evaluation and Claiming Education
Credit for detailed instructions on completing online
evaluation and credit request.
Physicians:
Physician Assistants:
ACCME Accreditation Statement
pmiCME is accredited by the Accreditation Council for
Continuing Medical Education to provide continuing
medical education for physicians.
AMA PRA Designation Statement
pmiCME designates this live activity for a maximum of
6.5 AMA PRA Category 1 credits™. Physicians should claim
only the credit commensurate with the extent of their
participation in the activity.
Family Practice Physicians:
This live activity, Primary Care Updates 1 from 10/15/14 to
10/15/14, has been reviewed and is acceptable for up to 6.5
prescribed credit(s) by the American Academy of Family
Physicians (AAFP).
NEW PROCESS for Evaluation and Claiming
Education Credit
Our credit award procedure has changed. Please follow
these instructions for evaluating and claiming continuing
education credit for sessions you attend at this Pri-Med
meeting:
1. Scan your badge. Be sure to scan your badge once
each day near the registration area to activate your
identification for your credit award.
2. Evaluate and Claim Credit. Using any internet-interactive
device go to www.pri-med.com/11MDW14A/eval to access
the evaluation and credit site. You have 7 days to complete this
process - until Oct. 25. A limited number of computers are
available onsite, and Pri-Med staff can assist you.
A. Enter your badge number and email address
for identification.
B. Select the day for the sessions you attended.
C. On the session screen, identify and evaluate
the sessions that you attended.
D. Confirm total credit award for each session and attest
to correct total. Designate the type of credit you seek.
3. Receive Your Credit. View and print your certificate
right from the evaluation web site. Your certificate will
also be posted to your Pri-Med.com account the next day.
This live activity, Primary Care Updates 2 from 10/15/14 to
10/15/14, has been reviewed and is acceptable for up to 6.5
prescribed credit(s) by the American Academy of Family
Physicians (AAFP).
Target Audience
This program is intended for clinicians in primary care, family
medicine, pediatrics, and internal medicine.
Learning Objectives*
• Evaluate new guidelines and evidence-based practices and
therapies.
• Enhance your ability to diagnose, treat, and manage health
problems you see in your practice.
• Draw on the experience of expert faculty and compare
your patient care practices with those of your colleagues to
help you improve your patients’ quality of life, encourage
the adoption of health-promoting behaviors, and avoid
unnecessary subspecialty consults.
*Individual sessions will post topic-specific learning objectives.
Faculty and Financial Disclosures
See pages 24-27 for a full list of program faculty and financial
disclosure information.
NEW PROCESS for Evaluation and Claiming
Education Credit
Please reference the green box to the left for the new
evaluation and claiming education credit process.
Physician Assistants:
AAPA accepts certificates of participation for educational
activities certified for AMA PRA Category 1 credit™ from
organizations accredited by ACCME. Physician assistants
may receive a Certificate of Attendance for a maximum of
19 hours of AMA PRA Category 1 credit™ for completing this
program.
Nurse Practitioners:
pmiCME is approved as a provider of nurse practitioner
continuing education by the American Association of Nurse
Practitioners. AANP provider 040308. This program has been
approved for 19 contact hours of continuing education
SESSION
CUMULATIVE
AMA PRA Category 1
Credits™ or
AMA PRA Category 1
Credits™ or
AANP Contact Hours
(AANP Pharmacology)*
AANP Contact Hours
(AANP Pharmacology)
Morning Sessions
3 (1.5)
3 (1.5)
Afternoon Sessions
4 (2.0)
7 (3.5)
Morning Sessions
3 (1.5)
10 (5.0)
Afternoon Sessions
4 (2.0)
14 (7.0)
Morning Sessions
3 (1.5)
17 (8.5)
Afternoon Sessions
2 (1.0)
19 (9.5)
Day 1
Day 2
Pri-Med Midwest Annual Conference
October 16–18, 2014
15
pmiCME designates this live activity for a maximum of
19 AMA PRA Category 1 credits™. Physicians should claim
only the credit commensurate with the extent of their
participation in the activity.
Family Practice Physicians:
This live activity, Pri-Med Annual Conference from 10/16/14
to 10/18/14, has been reviewed and is acceptable for up to
19 prescribed credit(s) by the American Academy of Family
Physicians (AAFP).
Accredited by the ACCME and approved as a provider of
continuing education by the AANP, pmiCME ensures that PriMed continuing education programs are high-quality, credited
learning experiences for participants, faculty speakers, and
supporters alike. pmiCME provides conferences, an online
learning platform, and innovative forms of distance education in
order to contribute to the continuing professional development
of health care providers and to influence clinical practice
behaviors for the purpose of improving health outcomes.
•
AMA PRA Designation Statement
About pmiCME
Pri-Med programs are owned and operated by DBC Pri-Med,
LLC, a division of Diversified Communications, located in Boston,
Massachusetts. The accredited provider for this program is
pmiCME, the accredited division of Pri-Med.
ROSEMONT
pmiCME is accredited by the Accreditation Council for
Continuing Medical Education to provide continuing
medical education for physicians.
ACCME Accreditation Statement
OC TOBER 2014
Day 3
Physicians:
Academic Partnerships
pmiCME and the American College of Physicians (ACP)
gratefully acknowledge Tufts Health Care Institute as an
academic partner providing independent expert reviews
of Annual Conference educational content.
ROSEMONT
•
OC TOBER 2014
16
Disclosure and Conflict of Interest Resolution Policy
pmiCME requires all individuals in a position to influence
educational content for pmiCME-certified CME activities
to disclose relevant personal financial relationship(s) with
commercial interests prior to contributing to the activity.
pmiCME assesses disclosed relationships and follows a
defined process to resolve real or implied conflicts to
ensure, to the best of our ability, that all educational
content is free of commercial bias. Financial disclosures
are listed in this guidebook and will also be announced
prior to the start of each presentation and posted on
www.pri-med.com.
Discussion of Off-Label Uses and Investigational
Products
During the course of their presentations, the faculty may
mention uses of products that have not been approved
in the United States for the indication(s) being discussed.
All presenters are instructed to notify participants when
they are discussing unapproved uses or investigational
agents. In addition, specific slides will include notation
of the off-label use or investigational agent being
discussed. Views presented during this program related
to unapproved uses of products are solely those of the
presenter(s) and are not endorsed by pmiCME or DBC
Pri-Med, LLC.
Disclaimer
No part of this program syllabus may be reproduced or otherwise
incorporated into any information retrieval system without
the written permission of DBC Pri-Med, LLC. The opinions,
recommendations, and perspectives expressed in the syllabus
and accompanying presentations are those of the faculty only
and do not necessarily reflect the opinions, recommendations,
or perspectives of their affiliated institutions, pmiCME, Diversified
Communications, or commercial supporters. Clinical judgment
must guide each clinician in weighing the benefit of any
intervention or treatment against the risk of the intervention or
treatment. Dosage, indications, and methods of use for products
referred to in this program are not necessarily the same as
indicated in the package insert for the product and may reflect
the clinical experience or expertise of the faculty speaker. No
procedures or treatments should be utilized without evaluation of
the patients’ conditions and/or possible contraindications or risks
and without a review of any applicable product information and
comparison with the recommendations of other authorities.
Ticketed Events
Information
A new ticketing policy is being implemented to give
all attendees equal opportunity to attend the Events
within the conference, such as Presentation Theaters
and Educational Symposia. Distribution of all
additional opportunity tickets will occur at the
Ticket Booth located in the Main Lobby on Level 1,
onsite on a first-come, first-served basis starting on
Thursday, October 16.
The Ticket Booth is located in the Main Lobby,
Level 1 and will be open during the following
hours, or until tickets are no longer available:
•
•
•
Thursday, October 16: 6:45am–4:30pm
Friday, October 17: 6:45am–4:30pm
Saturday, October 18: 6:45am–12pm
*The Ticket Booth will close once all available tickets have been distributed.
ARE YOU IN DIRECT
PRIMARY CARE?
WE’VE GOT AN EHR
THAT LEARNS WITH YOU.
Visit booth #223 to get an exclusive
sneak preview of the newest concept
in clinical documentation from the
team at Amazing Charts and Pri-Med.
Session Information
Session 4 – Improving Outcomes in Type 2
Diabetes: Integrating GLP-1 Receptor Agonists into
Multimodal Treatment Regimens
Session 1 – Current Approaches to Infectious
Diseases in Primary Care
Vivian A. Fonseca, MD
TBD
Mark E. Rupp, MD
Education Partner: Integritas Communications
Primary Care Updates Track 1
• Effectively assess and diagnose patients with common
community-acquired infections.
• Apply the latest guideline recommendations for appropriate
treatment of pharyngitis, urinary tract infection, and cellulitis.
Session 2 – Managing Shift Work Disorder in
Primary Care: Overcoming Barriers to Improve
Patient Outcomes
Karl Doghramji, MD
Session Information
ROSEMONT
•
OC TOBER 2014
18
• Describe the neurophysiologic mechanisms of circadian rhythms
and adverse multisystem consequences of misalignment for
patient health and function.
• Evaluate sleep patterns and symptoms of shift work disorder using
clinical tools and strategies such as sleep logs and the Epworth
Sleepiness Scale.
• Diagnose shift work disorder based on identified symptoms,
patient history and work schedule, and a comprehensive sleep
history.
• Tailor therapeutic regimens for shift work disorder that
include appropriate combinations of nonpharmacologic and
pharmacologic modalities.
• Educate patients on the potential consequences of poorly
managed shift work disorder and the fundamentals of sleep
hygiene.
• Discuss the pathologic mechanisms of T2DM that support the
need for prompt diagnosis and aggressive treatment.
• Identify patient-centered treatment goals for patients with T2DM
that encompass good overall glycemic control and improvements
in other clinical parameters.
• Evaluate the clinical profiles of GLP-1 receptor agonists for the
treatment of T2DM.
• Individualize therapeutic regimens for T2DM to maximize efficacy
and minimize hypoglycemia, weight gain, and other potential
treatment-related risks.
• Communicate with patients with T2DM about lifestyle
modifications, antihyperglycemic options, and the need for
treatment adherence.
Session 5 – Clinical Assessment of the Older Patient
for Driving Fitness
Linda Hill, MD, MPH
• Identify conditions that may put patients at risk for unsafe driving.
• Name the clinical screens to evaluate patients’ level of function for
driving fitness.
• State referral and treatment options for patients who require
further evaluation or are no longer fit to drive.
Primary Care Updates Track 2
Session 3 – Clinical Significance and Treatment of
Hypertriglyceridemia: Overcoming Challenging
Patient Cases
Session 1 – Psoriasis: It Runs Deeper Than You
Think. Optimizing Patient Communication
Management
Kevin Maki, PhD, CLS, FNLA
Education Partner: National Lipid Association
Education Partner: Vindico Medical Education
• Assess patients with elevated triglycerides for risks of
cardiovascular disease and/or pancreatitis.
• Explain the importance of managing both LDL-C and non-HDL-C
in patients with elevated triglycerides.
• Diagnose secondary causes of hypertriglyceridemia.
• Develop treatment plans for patients with elevated triglycerides
to achieve LDL-C and non-HDL-C targets both through lifestyle
modification and drug therapy.
• Assess the benefits and risks of emerging therapeutic approaches
for the management of hypertriglyceridemia.
• Design treatment regimens that encompass the full spectrum of
psoriasis, including systemic comorbidities, and refer patients to
specialists when appropriate.
• Utilize current safety data to assess risk-benefit profiles when
treating psoriasis, to improve clinical decision making and
individualize patient care.
• Incorporate counseling and active engagement into interactions
with patients with psoriasis to encourage conversations about
difficult-to-discuss issues and improve adherence to therapy.
Session Information
Hall A, Level 1
Education Partner: Miller Medical Communications, LLC
Education Partner: Vindico Medical Education
• Summarize the clinical evidence supporting the use of basal
insulin therapy, with and without GLP-1 receptor agonists, in the
management of type 2 diabetes.
• Incorporate strategies to overcome barriers to insulin use in the
treatment of type 2 diabetes.
Session 4 – A Hypoglycemia-Centric Approach to
the Management of Type 2 Diabetes
TBD
TBD
Education Partner: Horizon CME
• Apply strategies to individualize glycemic targets in patients with
type 2 diabetes.
• Discuss the limitations of frequently used conventional therapies
for the treatment of patients with type 2 diabetes.
• Outline the risk factors and clinical consequences of hypoglycemia.
• Implement strategies to minimize hypoglycemia risk in the
treatment of patients with type 2 diabetes.
Session 5 – A Focus on Bipolar Depression:
Overcoming Diagnostic Barriers and Optimizing
Long-Term Patient Outcomes
TBD
TBD
• Discuss clinically relevant pathophysiology of bipolar disorder,
including epidemiologic and mechanistic relationships with
cardiometabolic disturbances.
• Identify patients with bipolar depression based on comprehensive
patient histories, risk factors, key presenting symptoms, and the
latest diagnostic criteria.
• Tailor therapeutic regimens for bipolar depression to reflect
efficacy, safety, and tolerability of approved agents and common
patient comorbidities.
• Engage patients with bipolar depression to motivate active
participation in ongoing care and improve treatment adherence.
• Participants will be able to understand successful strategies for
motivating people to make and maintain comprehensive lifestyle
changes.
• Participants will be able to describe the evidence from randomized
controlled trials showing that chronic diseases such as coronary
heart disease and prostate cancer may be stopped or even
reversed by making comprehensive lifestyle changes.
• Participants will be able to describe evidence showing that
comprehensive lifestyle changes may affect gene expression.
Clinical Pearls in Pulmonary Medicine
• Use recommended diagnostic tests, patient history, and targeted
physical examination to identify pulmonary disease.
Hypertension Management: A Moving Target
• Review the JNC8 guidelines for hypertension in adults, with special
attention to new blood pressure goals.
• Consider patient factors such as age, co-morbidities, and race
when prescribing anti-hypertensive therapy.
Addressing Renal-Mediated Glucose Homeostasis:
Diabetes and the Kidney
Session Information
Frank Lavernia, MD
Richard Pratley, MD
Jeffrey Unger, MD
Dean Ornish, MD
19
Mark Stolar, MD
Education Partner: CE Health Interactive
• Recognize the role of the renal system in glucose uptake,
reabsorption, and the maintenance of glucose homeostasis and
use the achieved knowledge to identify patients who would
benefit from renally-targeted therapies.
• Explain the mechanism of action of sodium glucose linked
transporter inhibitors and their role in modulating glucose
homeostasis.
• Review professional guidelines from the ADA and AACE for target
goals of therapy and treatment recommendations for specific
patient-types.
• Identify the safety and efficacy profiles of current and emerging
therapies that target renally-mediated glucose uptake and
reabsorption.
• Implement management strategies that incorporate current and
emerging therapies into treatment paradigms for patients who
would benefit from a targeted approach to glycemic control.
OC TOBER 2014
Session 3 – Against All Odds: Improving Insulin Use
in T2DM through Individualized Clinical Decision
Making
The Power of Lifestyle Changes, Social Networks
& Trust
•
• Identify profiles of specific patients at greatest risk for vaccinepreventable diseases.
• Recognize that health care provider recommendations are key to
patient acceptance of vaccinations.
• Implement standing orders for adult immunization within practice
settings.
ROSEMONT
Annual Conference
Session 2 – Keeping Adult Patients Healthy: The
Role of Adult Immunization
Session Information
Comprehensive Management of Injury
and Chronic Pain
Update in Geriatrics 2014
James Atchison, DO
•
•
•
•
• Initiate a plan for rational use of drug therapy following injury.
• Recognize psychological “yellow flags” that suggest a patient is
developing a chronic pain syndrome.
• Identify the merits of an interdisciplinary approach to chronic pain
management.
Lyme Disease Update
• Recognize the clinical features of Lyme disease.
• Confirm Lyme disease diagnosis by appropriate serologic testing.
• Treat acute infection with recommended antimicrobial therapy.
A Tale of Two Brains
Session Information
20
• Explore the differences between right- and left-brain modes of
engagement.
• Understand why a right-brain mode may actually be beneficial for
the clinician.
Ultrasound for the PCP
• Identify the technology that has made ultrasound accessible to
primary care providers.
• Identify three advantages of offering ultrasound in the primary care
setting.
• Identify three clinical applications of point-of-care ultrasound in
primary care.
Employ interventions aimed at slowing memory loss.
Recognize and investigate unintentional weight loss.
Encourage simple strategies that can improve sleep.
Avoid medications known to adversely affect the elderly.
Top 10 Changes to My Practice 2014
Frank Domino, MD
• Review evolving concepts that may affect one’s practice.
• Recognize the effects of statin drugs on non-cardiovascular health
outcomes.
• Apply evidence-based strategies for treating common acute
infections in primary care.
• Identify diet and lifestyle interventions that are effective in
managing chronic disease.
Ultrasound Workshops
Richard Hoppmann, MD, and University of South Carolina School of
Medicine Ultrasound Institute faculty
• Identify the essential features of portable ultrasound systems.
• Understand important practical principles of ultrasound image
acquisition.
• Learn how to perform basic point-of-care ultrasound examinations
of the neck, the heart, the abdomen, and the knee.
• Learn how to perform ultrasound-guided procedures.
Annual Conference
ROSEMONT
•
OC TOBER 2014
Introduction to Ultrasound and Case Presentations
Victor Rao, MBBS, DMRD, RDMS
Michael Wagner, MD
Keith Barron, MD
• Understand the defining characteristics of point-of-care or focused
ultrasound examinations.
• Identify how point-of-care ultrasound can be used to diagnose and
manage heart failure, abdominal pain, musculoskeletal pain, and
soft-tissue infections.
Hot Off the Press and into Your Practice 2014
• Consider key findings from important new studies that can change
your patient care.
Medical Brain Game 2014: PCP Edition
John Russell, MD
Neil Skolnik, MD
• Compete in the popular yet practical medical knowledge game.
New categories are sure to provide a fun challenge.
Hall A, Level 1
Power Foods for the Brain
Neal Barnard, MD
• Participants will be able to describe foods that increase cognitive
function and boost folate, vitamin B6, and vitamin B12.
• Participants will be able to identify the effects of dairy and meat
products on memory.
• Participants will be able to explain the latest research on toxic
metals such as aluminums found in cookware, soda cans, and
common antacids.
Healthy Lifestyle Options
Frank Domino, MD
• Review data on common approaches for patients and providers to
help improve health.
• Discuss some novel approaches to traditional treatment
interventions.
• Consider advice on eating, exercise, and medication for primary
prevention.
Session Information
Diagnosis and Management of Depression in
Primary Care
Medical Literature Updates: Pediatric and Family
Medicine Edition
Cathy Frank, MD
Harvey Katz, MD
• Utilize simple, quick tools to screen for depression.
• Understand how changes in DSM-5 affect the diagnosis and
characterization of depressive disorders.
• Compare and contrast treatment modalities, including
pharmacotherapy and CBT.
• Use the clinical findings of the latest studies to inform changes in
patient care.
• Identify the core symptoms of ADHD.
• Consider patient factors and the pros and cons of ADHD drugs
when selecting treatment.
• Differentiate the signs and symptoms of functional bowel disorders
• Review evidence-based interventions that are directed at treating
predominant symptoms
Carpal Tunnel Syndrome
Treatment of Primary Headache Syndromes
• Recognize the signs and symptoms of carpal tunnel syndrome (CTS).
• Perform appropriate tests to confirm the diagnosis of CTS.
• Institute therapy according to CTS severity.
Daniel Evans, MD
• Past: Where does the PCMH fit within the broader health care
quality movement?
• Evidence: Is the PCMH model effective?
• Future: How do we go from the current fee-for-service model to a
national PCMH-like model?
• Impact: How will PCMH principles impact my practice starting in
2015?
David B. Conley, MD
• Discuss the importance of a careful patient history to confirm the
diagnosis of chronic sinusitis and possible etiology.
• Use the latest evidence-based guidelines to direct pharmacologic
and nonpharmacologic treatments.
Heart Failure Update for Primary Care
Choosing Wisely: How We Can Improve Value in
Health Care
• Understand the sources of health care cost problems in the US.
• Incorporate the tenets of high-value and low-value care into
everyday practice.
Annual Conference
Hall A, Level 1
Room 23, Level 2
Challenges with Patient Communication in a
Changing Health Care Environment
• Understand drivers of change in primary care physicians’ utilization
of health resources.
• Develop strategies to acknowledge patients’ concerns about
potential financial incentives affecting providers’ allocation of
medical resources.
21
David Baker MD, MPH
Allen S. Anderson, MD, FACC, FAHA
• Appropriately evaluate patients with symptoms of new or
worsening heart failure.
• Tailor treatment plans for heart failure patients based on heart
failure classification evidence-based guidelines.
Session Information
Assessment of Chronic Sinusitis
Patient-Centered Medical Home Model: A Guide for
the PCP
Laughter Is the Best Medicine
Brad Nieder, MD
• Understand laughter’s health benefits such as immune system
enhancement, pain management, and stress hormone reduction.
• Implement laughter’s workplace benefits such as team unity,
productivity, and creativity.
OC TOBER 2014
• Learn which complementary and alternative physical and
pharmacologic treatments are helpful for migraine.
• Determine which abortive treatments for migraine are most
effective.
• Learn a proper sequence of preventive medications for the
treatment of migraine.
• Understand abortive, transitional, and preventive treatment
strategies for cluster headache.
• Learn how to effectively treat tension-type headache.
•
Gerald W. Smetana, MD
Greg Dumanian, MD
ROSEMONT
William D. Chey, MD, AGAF, FACG, FACP
Thomas Cummins, MD
New Insights into Functional Bowel Disorders
Treatment of ADHD in Children and Adolescents
Session Information
Managing Common Issues in Menopausal Women
Kelly Anne Spratt, DO, FACC, FACP
• Examine the latest evidence regarding potential benefits and harms
of drugs and supplements used by menopausal women, especially
as they relate to cardiovascular health.
• Tailor therapy according to risks versus benefits of available
treatment interventions.
C Difficile Infection in the Community
Session Information
• Distinguish risk factors for C difficile infection (CDI) in an outpatient
with recent diarrheal symptoms.
• Consider the pros and cons of treatment modalities.
• Employ prevention measures for clinicians, patients, and
households.
OC TOBER 2014
•
ROSEMONT
Treatment of the Statin-Intolerant Patient
Matthew Sorrentino, MD, FACC, FASH
• Determine statin intolerance through trials of different agents and/
or assessment of risk for serious statin-related adverse effects.
• Consider lifestyle, diet, and pharmacologic options for managing
dyslipidemia in the statin-intolerant patient.
Update on Celiac Disease and Other
Gluten-Related Disorders
• Apply new recommendations for the diagnosis of celiac disease
and other gluten disorders.
• Counsel patients on dietary adjustments as indicated.
Dermatologic Manifestations of Systemic Disease
For Your Eyes Only – Ophthalmology 2014 Update
Julia R. Nunley, MD
• Identify the dermatologic manifestations of these systemic
conditions:
»» Systemic lupus erythematosus
»» Scleroderma
»» Dermatomyositis
»» Sarcoidosis
»» Paraneoplastic syndromes
• Discuss the latest results of the CATT trial and the AREDS2 trial and
their implications for age-related macular degeneration.
• Describe how to minimize the risk of ophthalmic adverse events in
patients taking alpha blockers for prostate disease.
• Discuss two new imaging modalities designed to help primary care
clinicians and ophthalmologists diagnose eye disease.
Organize Your Mind for Lifestyle Medicine
Margaret Moore, MBA
22
Room 23, Level 2
• Understand the causes of distracted thinking.
• Learn to use simple interventions to increase mindfulness.
Optimizing the Management of Patients
with Chronic Kidney Disease
Jay Wish, MD, FACP
• Understand the impact of chronic kidney disease (CKD) as a
common condition of the adult US population.
• Apply the latest evidence-based recommendations for diagnosis
and management of patients with stages 1 through 3 CKD.
• Slow CKD progression by treating risk factors such as hypertension
and diabetes.
FEATURED ACTIVITIES
Incretin-Based Therapies for Type
2 Diabetes: Mechanism-Based Strategies
to Achieve Patient-Centered Care
•
•
Multimedia/Webcast
Up to 1.00 credit*
Breakthroughs in New Treatment Options
for Obese Patients with Comorbidities
•
•
Multimedia/Webcast
Up to 1.75 credits*
Testosterone Replacement Therapy:
Controversies and Answers
•
•
Multimedia/Webcast
Up to 2.00 credits*
Insulin sensitivity affects propensity to
obesity in an ethnic-specific manner
•
•
Are All Probiotic Supplements Created Equal?
What PCPs Should Know to Improve GI Health
in their Patients
•
•
Text-based
Up to 0.50 credits*
Insulin Intensification in a 57-year-old
African American Woman on Basal Insulin
and Metformin
•
•
*pmiCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. pmiCME
designates these enduing activities for the above listed AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent
of their participation in each activity. pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Association of
Nurse Practitioners. AANP Provider number 040308. The above activities were planned in accordance with AANP CE Standards and Policies and AANP Commercial
Support Standards. These activities have been approved for the above listed contact hours. Please see activity CME information for full information on credit
designation and instructions.
**Pri-Med Qlikview database, July 2014
Text-based
Up to 0.25 credits*
Text-based
Up to 1.00 credit*
Provided by pmiCME
Faculty Information
Allen Anderson, MD
Cardiologist and Medical Director
Center for Heart Failure
Northwestern Bluhm Cardiovascular Institute
Professor of Medicine
Northwestern University Feinberg School of Medicine
Chicago, IL
Faculty Information
Vice Chair of Clinical Research
Associate Professor of Dermatology
Director, Clinical Trials and Outcomes Research
Director, Psoriasis Clinic
Department of Dermatology
Colorado Health Outcomes Program (COHO)
University of Colorado Denver School of Medicine
Denver, CO
OC TOBER 2014
•
ROSEMONT
Thomas Cummins, MD
Medical Director of Inpatient Psychiatry Services
Department of Child and Adolescent Psychiatry
The Ann and Robert H Lurie Children’s Hospital of Chicago
Assistant Professor
Department of Psychiatry and Behavioral Sciences
Chicago, IL
James W. Atchison, DO
Medical Director, Center for Pain Management
Rehabilitation Institute of Chicago
Chicago, IL
Karl Doghramji, MD
Michael A. Gertz Professor of Medicine
Chief, Division of General Internal Medicine and Geriatrics
Deputy Director, Institute for Public Health and Medicine
Feinberg School of Medicine
Northwestern University
Chicago, IL
Neal Barnard, MD
Adjunct Associate Professor of Medicine
George Washington School of Medicine
Washington, DC
Chief Resident
Primary Care Ultrasound Fellow
University of South Carolina School of Medicine
Columbia, SC
Michael Blaivas, MD, FACEP, FAIUM
Professor of Medicine, University of South Carolina School
of Medicine
President of the Society of Ultrasound in Medical Education
Columbia, SC
Director, Ochsner Diabetes Clinical Research Unit
Department of Endocrinology, Diabetes and Metabolism
Associate Internal Medicine Residency Program Director
Ochsner Medical Center
New Orleans, LA
Michael Bloch, MD, FASH
Associate Professor in Otolaryngology
Head and Neck Surgery
Chicago, IL
Baldino Professor of Sleep Medicine
Director, Division of Sleep Medicine
Harvard Medical School
Chief, Division of Sleep and Circadian Disorders
Departments of Medicine and Neurology
Brigham and Women’s Hospital
Boston, MA
24
David B. Conley, MD
Associate Professor
Department of Internal Medicine
University of Nevada School of Medicine
Medical Director
Vascular Medicine and Anticoagulation Services
Renown Heart and Vascular Institute
Reno, NV
Clinical Associate Professor of Medicine
Loyola University
Director, Division of Cardiology
Advocate Lutheran General Hospital
Advocate Medical Group
Park Ridge, IL
Thomas Jefferson University
Philadelphia, Pennsylvania
Senior Advisor, Lankenau Medical Associates
Lankenau Medical Center
Wynnewood, Pennsylvania
William Chey, MD, AGAF, FACG, FACP
Director, GI Physiology Laboratory
Co-Director, Michigan Bowel Control Program
H. Marvin Pollard Institute Scholar
Division of Gastroenterology
University of Michigan Health System
Ann Arbor, MI
Professor of Psychiatry, Neurology, and Medicine
Medical Director
Jefferson Sleep Disorders Center
Program Director
Fellowship in Sleep Medicine
Thomas Jefferson University
Philadelphia, PA
Family Physician
Collegeville Family Practice
Medical Director of Health Services
Ursinus College
Collegeville, PA
Frank Domino, MD
Professor and Clerkship Director
Family Medicine and Community Health
University of Massachusetts Medical School
Worcester, MA
Committee Member, Course Development
Boston, MA
Greg Dumanian, MD
Vice Chair of Clinical Affairs
Feinberg School of Medicine, Northwestern University
Chicago, IL
Chicago, IL
Daniel Evans, MD
Assistant Professor
Medicine-General Internal Medicine and Geriatrics
Chicago, IL
Member, Pulmonary and Critical Care Division
Brigham and Women’s Hospital
Associate Professor of Medicine
Boston, MA
Associate Chief
Division of Infectious Disease
Clinical Practice Director for Infectious Diseases
Director of the Infectious Diseases Fellowship Program
Medical Director
Northwestern Memorial Hospital Infectious Diseases Center
Chicago, IL
Vivian A. Fonseca, MD, FRCP
Professor of Medicine and Pharmacology
Tullis–Tulane Alumni Chair in Diabetes
Chief, Section of Endocrinology
Tulane University Health Sciences Center
New Orleans, LA
Cathy Frank, MD
Vice Chair of Clinical Affairs
Chicago, IL
Associate Professor of Dermatology and Epidemiology
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA
Kalpana Gupta, MD, MPH
Boston University School of Medicine
Chief, Section of Infectious Diseases
VA Boston Healthcare System
Boston, MA
Jeff Hall, MD
Assistant Professor in the Department of Family and
Preventive Medicine
Columbia, SC
Linda Hill, MD, MPH
Clinical Professor, Department of Family and Preventive
Medicine, University of California San Diego
Associate Professor of Health Promotion
Graduate School of Public Health, San Diego State
San Diego, CA
Robert H. Hopkins Jr., MD, FACP, FAAP
Professor of Internal Medicine and Pediatrics
University of Arkansas for Medical
Sciences College of Medicine
Little Rock, AK
The Dorothea H. Krebs Endowed Chair
of Ultrasound Education
Professor of Medicine and
Director of the Ultrasound Institute of the
Columbia, SC
Jeff Unger, MD
Medical Director
Unger Primary Care Medical Center
Chino, CA
Harvey Katz, MD
Associate Clinical Professor
Department of Population Medicine
Harvard Pilgrim Health Care Institute
Boston, Massachusetts
Attending Ophthalmologist
Sharp Rees-Stealy Medical Group
Sharp Memorial Hospital
San Diego, CA
Frank Lavernia, MD
Founder, North Broward Diabetes Center
Deerfield Beach, FL
Director of Clinical Research
The Celiac Center at BIDMC
Director of Quality Assurance
Division of Gastroenterology
Beth Israel Deaconess Medical Center
Boston, MA
Geriatrician
Associate Division Chief of Geriatrics
Chicago, IL
Faculty Information
Richard Vial Professor and Vice Chair
Louisiana State University Department of Medicine, LSU
Health Sciences Center
New Orleans, LA
Kevin C. Maki, PhD, CLS, FNLA
Chief Science Officer
Midwest Center for Metabolic & Cardiovascular Research
Glen Ellyn, IL
Jefferson Medical College
Philadelphia, PA
Matthew Sorrentino, MD, FASH, FACC
Professor
Sanford Burnham Medical Research Institute
Senior Scientist
Florida Hospital Sanford Burnham
Translational Research Institute
Orlando, FL
Department of Medicine, Section of Cardiology
University of Chicago Pritzker School of Medicine
Chicago, IL
Kelly Anne Spratt, DO, FACC, FACP
University of Pennsylvania
Philadelphia, PA
Victor Rao, MBBS, DMRD, RDMS
Director of Ultrasound Education
Radiology Research Assistant Professor of Radiology
Columbia, SC
Mark Stolar, MD
Associate Professor of Clinical Medicine
Attending Physician
Northwestern Memorial Hospital
Chicago, IL
Mark E. Rupp, MD
Margaret Moore, MBA
Founder, Wellcoaches School of Coaching
Wellesley, MA
Co-Founder and Co-Director
Institute of Coaching
McLean Hospital
Belmont, MA
Brad Nieder, MD
General Practitioner
Funny Doctor, Keynote Speaker, and Clean Comedian
Denver, CO
Julia Nunley, MD, FAAD, FACP
Professor and Program Director
Department of Dermatology
Medical College of Virginia Hospitals
Virginia Commonwealth University
Richmond, VA
Dean Ornish, MD
Richard E. Pratley, MD
Founder and President
Preventive Medicine Research Institute
Clinical Professor of Medicine
University of California
Cardiff, CA
Professor and Chief
Division of Infectious Diseases and Medical Director
Department of Infection Control & Epidemiology
University of Nebraska Medical Center
Michael Wagner, MD
Primary Care Ultrasound Fellow
Columbia, SC
John Russell, MD
Clinical Professor
Family and Community Medicine
Temple University School of Medicine
Philadelphia, PA
Director, Family Medicine Residency Program
Abington Memorial Hospital
Abington, PA
Assistant Professor of Medicine and Co-Director
Lipid Clinic
UCLA Medical Center
Los Angeles, CA
Neil Skolnik, MD
Jay Wish, MD, FACP
Professor, Family and Community Medicine
Temple University School of Medicine
Philadelphia, PA
Associate Director, Family Medicine Residency Program
Abington Memorial Hospital
Abington, PA
Professor of Clinical Medicine
Indiana University School of Medicine
Indianapolis, IN
Medical Director
Out-Patient Dialysis Unit
Indiana University Health Arnett Hospital
Lafayette, IN
Gerald Smetana, MD
Jeff Unger, MD
Division of General Medicine
Beth Israel Deaconess Medical Center
Boston, MA
American Board of Family Medicine
Director, Metabolic Studies
Catalina Research Institute
Chino, CA
Faculty Information
25
OC TOBER 2014
Exhibitor Information
Interactive Floor Maps
Session and Faculty Information
Personalized Planner
Up-to-the-Minute Conference Updates
Midwest 2014
October 15-18, 2014
Rosemont, IL
Donald E. Stephens
Convention Center
MOBILE APP SPONSORED BY:
The Pri-Med Midwest App has a powerful search engine,
planning tools, and interactive maps to make it
easy to get the most out of your time, discover
new products, navigate the Exhibit Hall and stay
up-to-date on all program-related news and events.
PRI-MED MOBILE APP IS A FREE DOWNLOAD
FOR ANDROID, IPHONE, AND BLACKBERRY
SEARCH FOR PRI-MED MDW
ROSEMONT
•
Social Media Connections
Primary Care
Updates Faculty
Serves as a consultant for AbbVie, Amgen, Janssen, Merck & Co., Lilly, and Pfizer; and Contracted Research for Amgen, Lilly, and Pfizer.
Research support from Eli Lilly and Company, Novo Nordisk A/S and sanofi-aventis US LLC. He receives honoraria for his role as a speaker from
AstraZeneca, Janssen Pharmaceuticals, Inc., Merck & Co., Novo Nordisk A/S, and sanofi-aventis US LLC. He receives honoraria for his role as a
consultant to AstraZeneca, GlaxoSmithKline, Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novo Nordisk A/S, Quest Diagnostics,
and sanofi-aventis U.S. LLC.
Speakers bureau for Merck and Regeneron; Medical advisory board for AstraZeneca, Merck, and Pfizer.
Received speaker honoraria from Merck & Co., Inc.
Consultant for Bombardier, Inc.; Teva Pharmaceuticals; Novartis Pharmaceuticals Corporation; Purdue Pharma; Vanda Pharmaceuticals, Inc.;
and Zeo, Inc. Received research support from Cephalon, Inc.; Philips Respironics; and ResMed Inc. Owns stock in Lifetrac, Inc.; Somnus
Therapeutics Inc.; and Vanda Pharmaceuticals Inc.
Karl Doghramji, MD
Consultant for Aptalis, Jazz Pharmaceuticals plc, and Vanda Pharmaceuticals Inc. Owns stock in Merck & Co., Inc.
Speakers bureau and advisory board member for Teva Pharmaceutical Industries, Ltd.
Vivian A. Fonseca, MD, FRCP
Receives grant research support via Tulane University from Abbott Laboratories; Eli Lilly and Company; GI Dynamics, Inc.; Novo Nordisk A/S;
Pan American Laboratories; Reata Pharmaceuticals Inc.; and sanofi-aventis U.S. LLC. Receives honoraria for consulting and lectures from
Abbott Laboratories; AstraZeneca; Boehringer Ingelheim GmbH; Bristol-Myers Squibb Company; Daiichi Sankyo Company, Limited; Eli Lilly
and Company; GlaxoSmithKline; Janssen Pharmaceuticals, Inc.; Novo Nordisk A/S; PamLab, Inc.; sanofi-aventis U.S. LLC; and Takeda
Pharmaceuticals U.S.A., Inc.
Serves as a consultant for Abbvie, Amgen Inc., Celgene Corp, Eli Lilly, Janssen Biologics (formerly Centocor), Merck, Novartis Corp, and
Pfizer Inc., receiving honoraria; has grants or has pending grants from Abbvie, Amgen Inc., Eli Lilly, Genentech Inc., Janssen, Novartis Corp,
and Pfizer Inc.; and received payment for continuing medical education work related to psoriasis.
Linda Hill, MD, MPH
No financial relationships to disclose.
Davida F. Kruger, MSN, APN-BC, BC-ADM Consultant for content development and faculty member, reports the following financial disclosures: Ms. Kruger report having received
honoraria for serving on Advisory Boards as a consultant for Dexcom, Takeda Pharmaceutical Company, Abbott Laboratories, Janssen
Pharmaceuticals, Eli Lilly, and Novo Nordisk. Ms. Kruger has also reports having received honoraria for her participation as a faculty-member on
Speakers’ Bureaus for Valeritas, Janssen Pharmaceuticals, Novo Nordisk, AstraZeneca/Bristol-Myers Squibb Diabetes, and Boehringer Ingelheim.
Frank Lavernia, MD
Advisory board member for Janssen Pharmaceuticals and Sanofi-Aventis.
Kevin C. Maki, PhD, CLS, FNLA
Speaker bureau member for GlaxoSmithKline and Amarin and medical advisory board member for Pharmavite Scientific Advisory Board. Had
been contracted to research for Dairy Research Inc. and Egg Nutrition Center as well as to consult for Omthera Pharmaceuticals, AstraZeneca,
Trugg Pharmaceuticals, Inspirion, and Matinas BioPharma.
Richard E. Pratley, MD
Research grants from Gilead Sciences, Elli Lilly, Novo Nordisk, Sanofi-Aventis, and Takeda. Speakers bureau member for Lilly, Merck, Novo
Nordisk, and Takeda. Receives honoraria from AstraZeneca/BMS, Boehringer Ingelheim, GlaxoSmithKline, Janssen Pharmaceuticals Inc.,
Elli Lilly, Merck, Novo Nordisk, Sanofi-Aventis, and Takeda. Consultant for AstraZeneca/BMS, Boehringer Ingelheim, Gilead Sciences,
GlaxoSmithKline, Janssen Pharmaceuticals Inc., Lilly, Merck, Novo Nordisk, Sanofi-Aventis, and Takeda.
Mark E. Rupp, MD
No disclosure information at time of printing.
Mark Stolar, MD
Speaker honorarium from Takeda and Vivus.
Jeff Unger, MD Participates in speakers bureau for Janssen Pharmaceuticals, Novo Nordisk and Valeritas. Serves as an advisor or consultant for Dance
Pharmaceuticals, Halozyme, Johnson and Johnson, Novo Nordisk, Sanofi-Aventis and Valeritas. Receives grants (paid directly to institution) for
clinical research from Boehringer-Ingelheim, GlaxoSmithKline, Johnson and Johnson, Lilly, Novo Nordisk, Pfizer and Sanofi-Aventis.
26
ROSEMONT
•
OC TOBER 2014
Primary Care Updates Planning and Review Disclosures
Nonfaculty contributors to planning, content development, and editing and review of content for Primary Care Updates representing pmiCME (including staff, advisory boards,
consultants, and contractors); the American College of Physicians; CE Health Interactive; Horizon CME: Integritas Communications; Miller Medical Communications, LLC; National Lipids
Association; Vindico Medical Education; and Tufts Healthcare Institute have nothing to disclose.
Neal Barnard, MD
Keith Barron, MD
Michael Blaivas, MD, FACEP, FAIUM
Consultant for GE.
William Chey, MD, AGAF, FACG, FACP
Consultant and investigator for Ironwood, Prometheus, Nestle, and Perrigo and a consultant for Astra-Zeneca, Froest, Sucampo, Takeda,
furiex, SK, Ferring, and Entera.
David B. Conley, MD
Serves as a consultant for Intersect Medical, Acclarent, and Xoran.
Thomas Cummins, MD
Frank Domino, MD
Greg Dumanian, MD
Daniel Evans, MD
Serves as a consultant for CVS Caremark National Pharmacy and Therapeutics Committee.
Cathy Frank, MD
Kalpana Gupta, MD, MPH
Receives fees for non-CME/CE services for UpToDate, Inc., and receives consulting feels from Boehringer Ingelheim GmbH and Melinta
Therapeutics. She and her spouse hold an ownership interest in Sarepta Therapeutics, Inc.; Seattle Genetics; Antares Pharma, Inc.; and
Novartis. Her spouse is employed by Novartis Corporation.
Jeff Hall, MD
Harvey Katz, MD
Daniel Leffler, MS, MD
Receives consulting fees from Alba Therapeutics, Alvine Therapeutics, GI Supply, Inova Diagnostics, and Shire Pharmaceuticals.
No financial relationships to disclose
Margaret Moore, MBA
Holds an ownership interest in Wellcoaches Corp; acts as a consultant for Coach, Jlm, and Sage; is employed by Wellcoaches Corp;
and acts as a part of the Curves Science Advisory Board.
Brad Nieder, MD
Julia Nunley, MD, FAAD , FACP
Dean Ornish, MD
Receives salary from Healthways as the president and director.
Victor Rao, MBBS, DMRD, RDMS No financial relationships to disclose.
John Russell, MD
Receives promotional honorarium from Sanofi Pasteur for speaking and teaching.
Neil Skolnik, MD
Receives consulting fees and promotional honoraria for speaking and teaching and is a member of the advisory committee for
AstraZeneca.
Gerald Smetana, MD
Matthew Sorrentino, MD, FACC
Kelly Anne Spratt, DO, FACC, FACP No financial relationships to disclose.
Michael Wagner, MD
Receives fees for non-CME/CE services as a Merck clinical trials adjucator.
Jay Wish, MD, FACP
Receives speaking/teaching honoraria from AMAG and Sanofi and consulting fees from Keryx, ZS Pharma, Hospira, and Kadence.
National Meeting Planning and Review Disclosures
Carolyn Skowronski, PharmD, pmiCME, owns stock in Merck. Other nonfaculty contributors to planning, content development, and editing and review of content for the
national meeting representing pmiCME (including staff, advisory boards, consultants, and contractors), American College of Physicians, and Tufts Healthcare Institute have
nothing to disclose.
27
OC TOBER 2014
•
Speakers bureau for Arbor Pharmaceuticals and does contracted research for CardioCell.
James W. Atchison, DO
ROSEMONT
Allen Anderson, MD
Annual Conference
Faculty
Exhibitors by Alphabetical Listing
AbbVie. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 306
Aegis Sciences Corporation. . . . . . . . . . . . . . . . . . . . . . . . . . 701
www.aegislabs.com
ALCAT. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 702
www.alcat.com
Alzheimer's Association. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 734
www.alz.org
Amazing Charts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 322
Exhibitor Information and Maps
www.amazingcharts.com
American College of Physicians. . . . . . . . . . . . . . . . . . . . . . 531
28
Aureus Medical Group. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 713
American Express Open . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 314
www.open.com
AMGEN. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 518
AndaMEDS. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 400
OC TOBER 2014
www.cryoprobe-na.com
CryoSurgery, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
www.cryosurgeryinc.com
Dermalogix Partners Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 416
www.dermalogix.com
Diva International Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 709
http://divacup.com/
Dr. Comfort. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 422
www.drcomfort.com
Edge Systems Corporation. . . . . . . . . . . . . . . . . . . . . . . . . . . 718
www.edgesystem.net
Eisai, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 506
Argyll Diagnostics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 235
Elsevier Medical Books. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 707
www.argylldiagnostics.com
www.elsevier.com
AstraZeneca. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 307
Essentia Health. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 601
www.astrazeneca-us.com
http://essentiahealth.org/careers
AstraZeneca. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 335
Exact Sciences. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 418
Atherotech. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 207
www.atherotech.com
www.aurorahealthcare.org
•
CryoProbe. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 607
www.eisai.com
Aurora Health Care . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 302
ROSEMONT
www.concentra.com
Arbor Pharmaceuticals, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . 339
www.aureuslocumtenens.com
Auxilium Pharmaceuticals, Inc.. . . . . . . . . . . . . . . . . . . . . . . 231
www.Auxilium.com
Biofilm, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 717
Bionix Medical Technologies. . . . . . . . . . . . . . . . . . . . . . . . . 617
www.bionixusa.com
Boehringer Ingelheim Pharmaceuticals, Inc.. . . . . . . . . . 107
http://us.boehringer-ingelheim.com
Calmoseptine . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 318
Concentra. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 419
www.calmoseptineointment.com
CardioDX, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 735
www.cardiodx.com
Carlson Laboratories. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 706
www.carlsonlabs.com
CME Corner/MCM Education . . . . . . . . . . . . . . . . . . . . . . . . 723
www.exactsciences.com
Exalenz Bioscience Ltd. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 326
www.exalenz.com
Genova Diagnostics, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 502
www.gdx.net
Gensco Laboratories. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 402
www.genscolabs.com
Gilead Sciences. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
www.gilead.com
Grifols USA, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 211
www.grifolsusa.com
HAE: Learn About It, Talk About It. . . . . . . . . . . . . . . . . . . . 303
Health Diagnostic Laboratory. . . . . . . . . . . . . . . . . . . . . . . . 630
www.myhdl.com
Hemosure Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 700
www.hemosure.com
ImpetoMedical. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 417
http://us.impeto-medical.com
Infinite Therapeutics. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 216
http://infinitetherapeutics.com/
www.mcmedu.com
Exhibitors by Alphabetical Listing
Janssen Pharmaceuticals, Inc.. . . . . . . . . . . . . . . . . . . . . . . . 427
Shire . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 602
Koven Technology. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 635
www.summitdoppler.com
www.koven.com
Laclede Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 217
www.laclede.com
Life Extension. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 219
www.lef.org
Lippincott Williams & Wilkins. . . . . . . . . . . . . . . . . . . . . . . . . 719
Summit Doppler/Wallach Surgical Devices. . . . . . . . . . . 121
Take Care Health Systems. . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
Televox Software, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 227
www.televox.com
Teva Respiratory. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 716
The Gideons International. . . . . . . . . . . . . . . . . . . . . . . . . . . 119
www.LWW.com
www.gideons.org
Magine Events. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 315
Ultimate Creations. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
http://magineevents.com/index.php
www.infinitealoe.com
MDSpiro. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 414
Verathon. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
www.micro-direct.com
www.verathon.com
Mederi Therapeutics, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 323
Vita-Mix Corp. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 114
MediTouch EHR / HealthFusion. . . . . . . . . . . . . . . . . . . . . . 430
www.healthfusion.com
Merck . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 317
www.merck.com
Monthly Prescribing Reference. . . . . . . . . . . . . . . . . . . . . . . 600
NeilMed Pharmaceuticals, Inc. . . . . . . . . . . . . . . . . . . . . . . . 308
www.vitamix.com
Wexford Health Sources . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 711
www.wexfordhealth.com
WynnPharm Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 415
www.wynnpharm.com
Xenna Corp.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 500
www.xenna.com
www.neilmed.com
Nutramax Laboratories, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . 209
www.nutramaxlabs.com
www.janssenpharmaceuticalsinc.com
29
Omron Healthcare. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 215
Orasure Technologies, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . 327
Pfizer Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 623, 631
www.pfizer.com
Physicians Committee for Responsible Medicine. . . . . 501
www.pcrm.org
Pri-Med. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 530
Pri-Med InLight. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 223
Pri-Med Knowledge Zone. . . . . . . . . . . . . . . . . . . . . . . . . . . . 611
Scarf King . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 214
Shader Productions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
www.rockmecz.com
•
Personna. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 725
ROSEMONT
www.irestmassager.com
Otto Trading, Inc.. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
OC TOBER 2014
www.orasure.com
Exhibitors by Product Category
Academia, Associations or Non-profit
Organizations
Alzheimer’s Association . . . . . . . . . . . . . . . . . 734
American College of Physicians . . . . . . . . . . . . . 531
OC TOBER 2014
•
ROSEMONT
Healthcare Network or Provider
Aurora Health Care . . . . . . . . . . . . . . . . . . . . 302
Concentra . . . . . . . . . . . . . . . . . . . . . . . . . . 419
Aureus Medical Group . . . . . . . . . . . . . . . . . . 713
Essentia Health . . . . . . . . . . . . . . . . . . . . . . . 601
Medical Device
Dr. Comfort . . . . . . . . . . . . . . . . . . . . . . . . . 422
CryoProbe . . . . . . . . . . . . . . . . . . . . . . . . . 607
Infinite Therapeutics . . . . . . . . . . . . . . . . . . . 216
CryoSurgery, Inc. . . . . . . . . . . . . . . . . . . . . . . 106
Monthly Prescribing Reference . . . . . . . . . . . . . 600
Diva International Inc. . . . . . . . . . . . . . . . . . . . 709
Otto Trading, Inc. . . . . . . . . . . . . . . . . . . . . . .117
Edge Systems Corporation . . . . . . . . . . . . . . . . 718
Scarf King . . . . . . . . . . . . . . . . . . . . . . . . . . 214
Exact Sciences . . . . . . . . . . . . . . . . . . . . . . . .418
Shader Productions . . . . . . . . . . . . . . . . . . . . .115
Exalenz Bioscience Ltd. . . . . . . . . . . . . . . . . . . 326
The Gideons International . . . . . . . . . . . . . . . . .119
ImpetoMedical . . . . . . . . . . . . . . . . . . . . . . . 417
Ultimate Creations . . . . . . . . . . . . . . . . . . . . . 116
Koven Technology . . . . . . . . . . . . . . . . . . . . . 635
Vita-Mix Corp. . . . . . . . . . . . . . . . . . . . . . . . .114
MDSpiro . . . . . . . . . . . . . . . . . . . . . . . . . . . 414
Dermatology
Mederi Therapeutics, Inc . . . . . . . . . . . . . . . . . 323
CME Corner/MCM Education . . . . . . . . . . . . . . . 723
Omron Healthcare . . . . . . . . . . . . . . . . . . . . . 215
HAE: Learn About It, Talk About It . . . . . . . . . . . . 303
Summit Doppler/Wallach Surgical Devices . . . . . . .121
Pri-Med . . . . . . . . . . . . . . . . . . . . . . . . . . . 530
Verathon . . . . . . . . . . . . . . . . . . . . . . . . . . 125
Pri-Med Knowledge Zone . . . . . . . . . . . . . . . . .611
Diagnostics, Laboratories & Testing
American Express Open . . . . . . . . . . . . . . . . . 314
Career, Recruitment & Clinician Network
Consumer Products & Services
30
Financial Services
Medical Supplies & Equipment
Biofilm, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . .717
ALCAT . . . . . . . . . . . . . . . . . . . . . . . . . . . . 702
Bionix Medical Technologies . . . . . . . . . . . . . . . 617
Argyll Diagnostics . . . . . . . . . . . . . . . . . . . . . 235
Laclede Inc. . . . . . . . . . . . . . . . . . . . . . . . . . 217
CardioDX, Inc. . . . . . . . . . . . . . . . . . . . . . . . 735
Personna . . . . . . . . . . . . . . . . . . . . . . . . . . 725
Aegis Sciences Corporation . . . . . . . . . . . . . . . 701
Nutrition & Wellness
Atherotech . . . . . . . . . . . . . . . . . . . . . . . . . 207
Carlson Laboratories . . . . . . . . . . . . . . . . . . . 706
Genova Diagnostics, Inc. . . . . . . . . . . . . . . . . . 502
Life Extension . . . . . . . . . . . . . . . . . . . . . . . .219
Grifols USA, Inc. . . . . . . . . . . . . . . . . . . . . . . .211
Nutramax Laboratories, Inc. . . . . . . . . . . . . . . . 209
Health Diagnostic Laboratory . . . . . . . . . . . . . . 630
Physicians Committee for Responsible Medicine . . . 501
Hemosure Inc. . . . . . . . . . . . . . . . . . . . . . . . 700
WynnPharm Inc. . . . . . . . . . . . . . . . . . . . . . . .415
Orasure Technologies, Inc. . . . . . . . . . . . . . . . . 327
Education
Pri-Med . . . . . . . . . . . . . . . . . . . . . . . . . . . 530
OTC Medicine and Treatment
NeilMed Pharmaceuticals, Inc. . . . . . . . . . . . . . . 308
Xenna Corp. . . . . . . . . . . . . . . . . . . . . . . . . . 500
Pri-Med Knowledge Zone . . . . . . . . . . . . . . . . .611
Exhibitors by Product Category
AbbVie . . . . . . . . . . . . . . . . . . . . . . . . . . . . 306
AMGEN . . . . . . . . . . . . . . . . . . . . . . . . . . . 518
Pharmacy
Take Care Health Systems . . . . . . . . . . . . . . . . . 108
Practice Management
Arbor Pharmaceuticals, Inc. . . . . . . . . . . . . . . . 339
Amazing Charts . . . . . . . . . . . . . . . . . . . . . . 322
AstraZeneca . . . . . . . . . . . . . . . . . . . . . . . . 307
AndaMEDS . . . . . . . . . . . . . . . . . . . . . . . . . 400
AstraZeneca . . . . . . . . . . . . . . . . . . . . . . . . 335
MediTouch EHR / HealthFusion . . . . . . . . . . . . . 430
Auxilium Pharmaceuticals, Inc. . . . . . . . . . . . . . . 231
Pri-Med InLight . . . . . . . . . . . . . . . . . . . . . . . 223
Boehringer Ingelheim Pharmaceuticals, Inc. . . . . . . 107
Televox Software, Inc. . . . . . . . . . . . . . . . . . . . 227
Eisai, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . 506
Wexford Health Sources . . . . . . . . . . . . . . . . . .711
Gensco Laboratories . . . . . . . . . . . . . . . . . . . 402
Gilead Sciences . . . . . . . . . . . . . . . . . . . . . . 123
Janssen Pharmaceuticals, Inc. . . . . . . . . . . . . . . 427
Pfizer Inc. . . . . . . . . . . . . . . . . . . . . . . . . 623, 631
Merck . . . . . . . . . . . . . . . . . . . . . . . . . . . . .317
Publishing
Elsevier Medical Books . . . . . . . . . . . . . . . . . . 707
Lippincott Williams & Wilkins . . . . . . . . . . . . . . 719
Magine Events . . . . . . . . . . . . . . . . . . . . . . . .315
Shire . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 602
Teva Respiratory . . . . . . . . . . . . . . . . . . . . . . 716
Pharmaceutical
ROSEMONT
•
OC TOBER 2014
31
PLEASE NOTE: FLOOR PLANS ARE SUBJECT TO CHANGE
Expoteria Restaurant
Fire Exits
Exhibit Hall
Fire Exits
Fire Exits
Fire Exits
Fire
Exits
Stairs
Product
Theater
Product
Theater
#1
To
Expoteria
#2
RD
Concession
RD
Auxilium
Pharm
339
Argyll
Diagnostics
430
431
Salix
Pharm
531
American
College of
Physicians
Pri-Med
131
230
128
127
228
530
335
227
635
734
735
Health
Diag
Lab
732
733
630
730
731
AstraZeneca
235
130
Pfizer, Inc.
631
336
327
121
Gilead
Sciences
123
426
PriMed
InLight
Amazing
Charts
325
424
223
322
323
422
727
Pfizer, Inc.
Pharmaceuticals, Inc
725
427
623
723
TO GENERAL
SESSION
OC TOBER 2014
men
I.C.E,
Inc,
219
318
116
117
216
217
•
119
114
115
214
217
314
ROSEMONT
Ultimate
Creations
American
Express
Take
Care
Health
Systems
108
Men
GENERAL SESSION
HALL A
231
125
Payphone
RD
150
Janssen
Payphone
RD
106
418
419
518
Bionix
Medical
Tech
718
719
317
416
417
516
617
716
717
315
414
415
514
Merck
715
515
713
Pri-Med
Knowledge
Zone
Boehringer
Ingelheim
Pharmaceuticals
Inc
107
211
611
Neilmed
Pharm
AstraZeneca
209
308
207
306
711
Eisai, Inc
709
607
506
307
707
706
TO GENERAL
SESSION
To
Registration
302
303
400
402
500
501
502
600
601
602
700
701
702
Mech.
535
32
RES Service Center
SALES
OFFICE
Handicap Ramp
TO GENERAL
SESSION
MAIN ENTRANCE
TO GENERAL
SESSION
RE
Registration
EXHIBIT HALL
info
counter
REGISTRATION
Men
TO GENERAL
SESSION
Women
Rosemont
Convention
Bureau
33
TICKET
BOOTH
OC TOBER 2014
FH
Escalators
Business
Center
ROSEMONT
•
Pay
Phones
Elevators
Stairs
Mech.
FH
Sprinkler
Equip.
•
OC TOBER 2014
34
AMAZING
CHARTS
USER
CONFERENCE
ROOM 4
ROOM 1
PRESENTATION # 3
(10/16-10/18)
WOMEN
WOMEN
AMAZING
CHARTS
F&B/
EXHIBITS
ROOM 3
MEN
MEN
FIRE EXITS
CONCESSION
FREIGHT
ELEVATOR
ESCALATORS
ROSEMONT
ELEVATOR
Level 1
VESTIBULE
KITCHEN
DISHWASHER ROOM
freight
elevator
ROSEMONT
•
OC TOBER 2014
ROOM 23
escalat
or
escalat
or
ACP SESSION# 2
ROOM 29
STAIRS
COATS
women
coat
check
elevator
coat
check
men
USC
DEMO
Room# 43
Show Mgmt
Office
ROOM#41
DN
SYMPOSIA
Level 2
STAIRS
DN
RM 54
New
Mother's
Room
35
FHS 4
DN
DN
WOMEN'S
MENS
Clinicians Love
Amazing Charts
Integrated
Practice Management
Coming Nov. 2014!
“ Unlike other EHRs, Amazing Charts actually lets me have more
face-to-face time with patients.”
– Dr. James Legan, Internal Medicine
“I felt comfortable switching from our former EHR to Amazing Charts.
They were very responsive to any issues we had during our transition.”
– Dr. Vishal Datta, Endocrinology
“ Amazing Charts is so easy to use we actually get home
in time for dinner. Our kids can’t believe it!”
– Drs. Jennifer and David Benson, Family Medicine
Download your FREE trial at booth #322!
amazingcharts.com/trial
866-382-5932

PRI-MED MIDWEST

Transcription

Similar documents

Pat Ambrosic, Level I Trainer

Zanies $5.00 Coupon (Version 2)

ROSEMONT.COM

June 2016 - Sri Atmananda Memorial School

FOOD SCRAP DIVERSION

No Work, All Play!

The name is now

They`ll Be Driving Big Black Express Clydesdales at the 2015